Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance ...

He cited a study that found that although the U.S. has the costliest healthcare system in the world, it ranks 42nd in life ...

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

Robert F. Kennedy Jr., President-elect Donald Trump’s choice to lead the U.S. Department of Health and Human Services, has ...

Obesity is down in the US for the first time in a decade. A new study suggests weight-loss drugs may explain why.

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

Popular GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight, but what should patients know about ...

Recent studies show medications like Ozempic, originally designed for type 2 diabetes and weight loss, may help people ...

The weight-loss drug Ozempic could increase the risk of vision loss, a new study found. Ozempic has been hailed as a ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...